FOLD - Amicus Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

FOLD is currently covered by 5 analysts with an average price target of $14.5. This is a potential upside of $0.01 (0.07%) from yesterday's end of day stock price of $14.49.

Our record on Amicus Therapeutics covers 21 analysts since 2008; 5 cover it today. Of the 140 price targets those analysts set on FOLD, 76 were reached (54%). The highest performance score on Amicus Therapeutics belongs to Anupam Rama of JPMorgan: 2.95, with 8 of 17 targets met in 354 days on average. The latest calls: Ritu Baral of TD Cowen kept the target at $14.50 with a Hold rating on 19 Feb 2026; Dennis Ding of Jefferies cut the target to $14.50 from $18 with a Buy rating on 22 Jan 2026; Joseph Schwartz of Leerink raised the target to $14.50 from $14 with a Buy rating on 29 Dec 2025. Figures as of 18 Nov 2026.

Amicus Therapeutics's activity chart (see below) currently has 185 price targets and 137 ratings on display. The stock rating distribution of FOLD is 75% BUY and 25% HOLD.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 53.01% of the time, taking 345.56 days on average.

Highest price target for FOLD is $14.5, Lowest price target is $14.5, average price target is $14.5.

Most recent stock forecast was given by RITU BARAL from TD COWEN on 19-Feb-2026. First documented stock forecast 30-Jun-2014.

Currently out of the existing stock ratings of FOLD, 6 are a BUY (75%), 2 are a HOLD (25%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 27-Jan-2026

$14.5

$0.01 (0.07%)

$14.5

9 months 3 days ago
(19-Feb-2026)

5/16 (31.25%)

$0.15 (1.05%)

679

Buy Since 06-Sep-2024

$14.5

$0.01 (0.07%)

$18

10 months ago
(22-Jan-2026)

0/2 (0%)

$0.23 (1.61%)

Buy Since 24-Feb-2022

$14.5

$0.01 (0.07%)

$14

10 months 24 days ago
(29-Dec-2025)

12/16 (75%)

$0.25 (1.75%)

564

Buy Since 17-Dec-2025

$14.5

$0.01 (0.07%)

$17

11 months ago
(22-Dec-2025)

0/2 (0%)

$0.29 (2.04%)

Buy Since 13-Jan-2022

$14.5

$0.01 (0.07%)

$21

11 months 3 days ago
(19-Dec-2025)

0/9 (0%)

$0.32 (2.26%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is FOLD (Amicus Therapeutics) average time for price targets to be met?

On average it took 346 days for the stock forecasts to be reached, with an average price target met ratio of 53.01%.

Which analyst most recently updated their price target on FOLD (Amicus Therapeutics)?

Ritu Baral

Which analyst has the most public recommendations on FOLD (Amicus Therapeutics)?

Ritu Baral works at TD COWEN and has 7 price targets and 5 ratings on FOLD

Which analyst is the currently most bullish on FOLD (Amicus Therapeutics)?

Michael Ulz with the highest potential upside of $10.51

Which analyst is the currently most reserved on FOLD (Amicus Therapeutics)?

Salveen Richter with the lowest potential downside of -$5.49
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?